Upstream Bio - 53 Year Dividend History | UPB
Historical dividend payout and yield for Upstream Bio (UPB) since 1971. The current TTM dividend payout for Upstream Bio (UPB) as of November 21, 2024 is $0.00. The current dividend yield for Upstream Bio as of November 21, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.954B |
$0.000B |
|
Upstream Bio Inc. is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. The Company is developing verekitug, the only known antagonist currently in development which targets the receptor for thymic stromal lymphopoietin, a cytokine which is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune mediated diseases. Upstream Bio Inc. is based in WALTHAM, Mass.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
